X

Lupin Ltd Q1FY24; 29% rise in Revenue

Lupin is engaged in the business of Manufacture of Pharmaceuticals.

Financial Results:

Lupin Ltd reported Revenues for Q1FY24 of ₹4,814.00 Crores up from ₹3,744.00 Crore year on year, a rise of 28.58%.

Total Expenses for Q1FY24 of ₹4,279.00 Crores up from ₹3,748.00 Crores year on year, a rise of 14.17%.

Consolidated Net Profit of ₹453.00 Crores from -₹87.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹9.94, from -₹1.96 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post